TWC
SGMO

TD Waterhouse Canada’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

TD Waterhouse Canada’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31
Closed -$25 – 2043
2024
Q3 		$25 Hold
31
– – ﹤0.01% 1867
2024
Q2 		$10 Buy
+31
New +$17 ﹤0.01% 1899
2024
Q1 		– Sell
-1,031
Closed -$511 – 1922
2023
Q4 		$511 Sell
1,031
-1,500
-59% -$692 ﹤0.01% 1594
2023
Q3 		$1.53K Hold
2,531
– – ﹤0.01% 1523
2023
Q2 		$3.29K Hold
2,531
– – ﹤0.01% 1462
2023
Q1 		$4.38K Hold
2,531
– – ﹤0.01% 1399
2022
Q4 		$7.95K Hold
2,531
– – ﹤0.01% 1256
2022
Q3 		$12.1K Hold
2,531
– – ﹤0.01% 1202
2022
Q2 		$10.8K Hold
2,531
– – ﹤0.01% 1239
2022
Q1 		$15.3K Hold
2,531
– – ﹤0.01% 1231
2021
Q4 		$18.8K Buy
+2,531
New +$22K ﹤0.01% 1221

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

TD Waterhouse Canada's SGMO Position: Q4 2024 in Review

TD Waterhouse Canada sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 31 shares — an estimated $25 sold.

TD Waterhouse Canada first reported a position in SGMO in Q4 2021 and held it in 11 quarters. The position peaked at $18.8K in Q4 2021. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • TD Waterhouse Canada reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 31 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $25.
  • TD Waterhouse Canada first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 11 quarters.
  • TD Waterhouse Canada's SANGAMO THERAPEUTICS INC position peaked at $18.8K in Q4 2021.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on TD Waterhouse Canada's 13F filing for Q4 2024, filed 13 Feb 2025.